Literature DB >> 27621773

Application of appropriate use criteria for percutaneous coronary intervention in Japan.

Taku Inohara1, Shun Kohsaka1, Ikuko Ueda1, Takashi Yagi1, Yohei Numasawa1, Masahiro Suzuki1, Yuichiro Maekawa1, Keiichi Fukuda1.   

Abstract

The aim of this review was to summarize the concept of appropriate use criteria (AUC) regarding percutaneous coronary intervention (PCI) and document AUC use and impact on clinical practice in Japan, in comparison with its application in the United States. AUC were originally developed to subjectively evaluate the indications and performance of various diagnostic and therapeutic modalities, including revascularization techniques. Over the years, application of AUC has significantly impacted patient selection for PCI in the United States, particularly in non-acute settings. After the broad implementation of AUC in 2009, the rate of inappropriate PCI decreased by half by 2014. The effect was further accentuated by incorporation of financial incentives (e.g., restriction of reimbursement for inappropriate procedures). On the other hand, when the United States-derived AUC were applied to Japanese patients undergoing elective PCI from 2008 to 2013, about one-third were classified as inappropriate, largely due to the perception gap between American and Japanese experts. For example, PCI for low-risk non-left atrial ascending artery lesion was more likely to be classified as appropriate by Japanese standards, and anatomical imaging with coronary computed tomography angiography was used relatively frequently in Japan, but no scenario within the current AUC includes this modality. To extrapolate the current AUC to Japan or any other region outside of the United States, these local discrepancies must be taken into consideration, and scenarios should be revised to reflect contemporary practice. Understanding the concept of AUC as well as its perception gap between different counties will result in the broader implementation of AUC, and lead to the quality improvement of patients' care in the field of coronary intervention.

Entities:  

Keywords:  Acute coronary syndrome; Appropriate use criteria; Japan; Percutaneous coronary intervention; Stable ischemic heart disease

Year:  2016        PMID: 27621773      PMCID: PMC4997526          DOI: 10.4330/wjc.v8.i8.456

Source DB:  PubMed          Journal:  World J Cardiol


  29 in total

Review 1.  ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association.

Authors:  Ralph G Brindis; Pamela S Douglas; Robert C Hendel; Eric D Peterson; Michael J Wolk; Joseph M Allen; Manesh R Patel; Ira E Raskin; Robert C Hendel; Timothy M Bateman; Manuel D Cerqueira; Raymond J Gibbons; Linda D Gillam; John A Gillespie; Robert C Hendel; Ami E Iskandrian; Scott D Jerome; Harlan M Krumholz; Joseph V Messer; John A Spertus; Stephen A Stowers
Journal:  J Am Coll Cardiol       Date:  2005-10-18       Impact factor: 24.094

Review 2.  ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine.

Authors:  Pamela S Douglas; Bijoy Khandheria; Raymond F Stainback; Neil J Weissman; Ralph G Brindis; Manesh R Patel; Bijoy Khandheria; Joseph S Alpert; David Fitzgerald; Paul Heidenreich; Edward T Martin; Joseph V Messer; Alan B Miller; Michael H Picard; Paolo Raggi; Kim D Reed; John S Rumsfeld; Anthony E Steimle; Russ Tonkovic; Krishnaswami Vijayaraghavan; Neil J Weissman; Susan Bok Yeon; Ralph G Brindis; Pamela S Douglas; Robert C Hendel; Manesh R Patel; Eric Peterson; Michael J Wolk; Joseph M Allen
Journal:  J Am Coll Cardiol       Date:  2007-07-10       Impact factor: 24.094

3.  Development and validation of a pre-percutaneous coronary intervention risk model of contrast-induced acute kidney injury with an integer scoring system.

Authors:  Taku Inohara; Shun Kohsaka; Takayuki Abe; Hiroaki Miyata; Yohei Numasawa; Ikuko Ueda; Yutaro Nishi; Kotaro Naito; Masaru Shibata; Kentaro Hayashida; Yuichiro Maekawa; Akio Kawamura; Yuji Sato; Keiichi Fukuda
Journal:  Am J Cardiol       Date:  2015-03-23       Impact factor: 2.778

4.  Temporal Trends in Percutaneous Coronary Intervention Appropriateness: Insights From the Clinical Outcomes Assessment Program.

Authors:  Steven M Bradley; Chad M Bohn; David J Malenka; Michelle M Graham; Chris L Bryson; James M McCabe; Jeptha P Curtis; Anne Lambert-Kerzner; Charles Maynard
Journal:  Circulation       Date:  2015-05-28       Impact factor: 29.690

5.  Appropriateness of percutaneous coronary intervention.

Authors:  Paul S Chan; Manesh R Patel; Lloyd W Klein; Ronald J Krone; Gregory J Dehmer; Kevin Kennedy; Brahmajee K Nallamothu; W Douglas Weaver; Frederick A Masoudi; John S Rumsfeld; Ralph G Brindis; John A Spertus
Journal:  JAMA       Date:  2011-07-06       Impact factor: 56.272

6.  Appropriateness of coronary interventions in Japan by the US and Japanese standards.

Authors:  Taku Inohara; Shun Kohsaka; Hiroaki Miyata; Ikuko Ueda; Shigetaka Noma; Masahiro Suzuki; Koji Negishi; Ayaka Endo; Yutaro Nishi; Kentaro Hayashida; Yuichiro Maekawa; Akio Kawamura; Takahiro Higashi; Keiichi Fukuda
Journal:  Am Heart J       Date:  2014-09-16       Impact factor: 4.749

7.  Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.

Authors:  William B Borden; Rita F Redberg; Alvin I Mushlin; David Dai; Lisa A Kaltenbach; John A Spertus
Journal:  JAMA       Date:  2011-05-11       Impact factor: 56.272

8.  A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011.

Authors:  Gregory J Dehmer; Douglas Weaver; Matthew T Roe; Sarah Milford-Beland; Susan Fitzgerald; Anthony Hermann; John Messenger; Issam Moussa; Kirk Garratt; John Rumsfeld; Ralph G Brindis
Journal:  J Am Coll Cardiol       Date:  2012-10-17       Impact factor: 24.094

9.  Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study.

Authors:  Kazuhiko Nishigaki; Tsutomu Yamazaki; Akira Kitabatake; Tetsu Yamaguchi; Katsuo Kanmatsuse; Itsuo Kodama; Noboru Takekoshi; Hitonobu Tomoike; Masatsugu Hori; Masunori Matsuzaki; Akira Takeshita; Takuro Shimbo; Hisayoshi Fujiwara
Journal:  JACC Cardiovasc Interv       Date:  2008-10       Impact factor: 11.195

10.  Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.

Authors:  Nihar R Desai; Steven M Bradley; Craig S Parzynski; Brahmajee K Nallamothu; Paul S Chan; John A Spertus; Manesh R Patel; Jeremy Ader; Aaron Soufer; Harlan M Krumholz; Jeptha P Curtis
Journal:  JAMA       Date:  2015-11-17       Impact factor: 56.272

View more
  1 in total

1.  Cardiovascular disease history and β-blocker prescription patterns among Japanese and American patients with CKD: a cross-sectional study of the CRIC and CKD-JAC studies.

Authors:  Takahiro Imaizumi; Takayuki Hamano; Naohiko Fujii; Jing Huang; Dawei Xie; Ana C Ricardo; Jiang He; Elsayed Z Soliman; John W Kusek; Lisa Nessel; Wei Yang; Shoichi Maruyama; Masafumi Fukagawa; Harold I Feldman
Journal:  Hypertens Res       Date:  2021-01-22       Impact factor: 3.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.